Lv51
818 积分 2021-01-22 加入
Engineering Strategies for Lymph Node Targeted Immune Activation
29分钟前
待确认
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
10天前
已完结
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
10天前
已完结
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
10天前
已完结
NFAT proteins: key regulators of T-cell development and function
13天前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
20天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
21天前
已完结
Dual-Targeting BCMA-CD19 CAR-T Cell Therapy in Systemic Lupus Erythematosus: Single-Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution
24天前
已完结
IL-7 and CD4 T Follicular Helper Cells in HIV-1 Infection
24天前
已完结
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
24天前
已完结
皖公网安备34019202002308
